Skip to main content
. 2019 Jun 6;10:1319. doi: 10.3389/fimmu.2019.01319

Figure 4.

Figure 4

Defective IFN-γ production ex vivo by HBV core18−27-pentamer-stained CD8+ T cells in the IT phase after peptide stimulation. (A,B) Secretion of IFN-γ by bulk and pentamer+ CD8+ T cells as examined using the cytokine secretion assays. (A) Representative dotplot describing the proportion of IFN-γ-secreting cells after peptide stimulation. (B) Proportion of IFN-γ-secreting cells after HBV peptide stimulation in each patient sample analyzed. Anti-CD3 antibody was used for a positive control. AT, antiviral treatment; DMSO, dimethyl sulfoxide; IA, immune-active; IFN, interferon; IT, immune-tolerant.